Cardiac disease monitoring measures in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Bampatsias, D., Wardhere, A., Zeldin, L., Mirabal-Santos, A., Weinsaft, A. Y., Levy, J. C., Smiley, D., Teruya, S. L., & Maurer, M. S. (2025). Cardiac disease monitoring measures in patients with transthyretin amyloid cardiomyopathy treated with tafamidis. Heart, heartjnl-2024-324826. https://doi.org/10.1136/heartjnl-2024-324826
Authors:
Dimitrios Bampatsias
Abdirahman Wardhere
Lawrence Zeldin
Alfonsina Mirabal-Santos
Ariel Y Weinsaft
Juliana C Levy
Dia Smiley
Sergio L Teruya
Mathew S Maurer
Affiliated Authors:
Dimitrios Bampatsias
Abdirahman Wardhere
Lawrence Zeldin
Alfonsina Mirabal-Santos
Ariel Y Weinsaft
Juliana C Levy
Dia Smiley
Sergio L Teruya
Mathew S Maurer
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1136/heartjnl-2024-324826
PMID:
40122587
DOI:
10.1136/heartjnl-2024-324826
Journal:
Heart
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: